por
Nowicki, Michael, 1952-
Signatura topográfica preferida
362.110681 22
Fecha de publicación
2011
Formato:
Recursos electrónicos
Relevancia:
60618.3867
por
Ott, Cathy D.
Signatura topográfica preferida
362.1756 23
Fecha de publicación
2011
Formato:
Recursos electrónicos
Relevancia:
57338.0938
Ver otros resultados de búsqueda
por
Friedman, Leonard H., author.
Signatura topográfica preferida
362.1068 23
Fecha de publicación
2013
Resumen
"Careers in health administration continue to grow despite an overall downturn in the economy. This is a field that offers tremendous job opportunities across the spectrum of health care delivery and payment organizations. 101 Careers in Health Care Management is the only comprehensive guide to careers in health administration ranging from entry level management positions up to the most senior executive opportunities. The guide provides prospective students with a clear picture of the integral role played by health care administrators in creating and sustaining the systems that allow clinicians to do their best work. It explains exactly what health care managers do and how these careers differ from other management jobs. The book covers educational requirements and opportunities, traditional and non-traditional career pathways, and helps students to assess whether they are temperamentally and intellectually suited to a career in health care management. Based on the most current data from the US Department of Labor and professional societies in health care management, the guide describes 101 careers in 14 different health care and related settings along with the responsibilities and duties of each. Additionally, the book includes numerous interviews with health administrators from entry level positions to CEOs to create more vivid portraits of potential careers"--Provided by publisher.
Formato:
Recursos electrónicos
Relevancia:
57336.3320
por
Gapenski, Louis C.
Signatura topográfica preferida
362.1068 22
Fecha de publicación
2011
Formato:
Recursos electrónicos
Relevancia:
52745.5117
por
Haddow, George D.
Signatura topográfica preferida
363.3480973 22
Fecha de publicación
2008
Formato:
Recursos electrónicos
Relevancia:
49104.9531
por
Saunders, Elijah.
Signatura topográfica preferida
616.132008996073 22
Fecha de publicación
2009
Formato:
Recursos electrónicos
Relevancia:
47544.9531
por
McSweeney-Feld, Mary Helen.
Signatura topográfica preferida
362.16068 23
Fecha de publicación
2012
Formato:
Recursos electrónicos
Relevancia:
47542.6172
por
Institute for Career Research.
Signatura topográfica preferida
610.69023 22
Fecha de publicación
2007
Formato:
Recursos electrónicos
Relevancia:
38035.4336
por
Dixon, Lloyd S.
Signatura topográfica preferida
368.48 22
Fecha de publicación
2007
Resumen
Concerned that the unavailability of terrorism insurance would impede economic recovery and hinder growth after the 9/11 attacks, Congress passed the Terrorism Risk Insurance Act of 2002 (TRIA). TRIA will sunset at the end of 2007 unless Congress takes further action. This book examines the implications of allowing TRIA to expire and of enhancements aimed at improving the availability and affordability of insurance for nuclear, biological, chemical, and radiological (NBCR) attacks. The analysis takes a systematic approach to addressing the deep uncertainties that underlie the market for terrorism insurance and is the first study of TRIA to consider not just taxpayer payments through the program but also the cost of government compensation and assistance following a terrorist attack when analyzing the program's effect on government spending. The authors conclude that taxpayer cost is lower with TRIA than without TRIA across a broad range of assumptions about attack frequency and the proportion of uninsured losses that are compensated postattack. The analysis also cautions policymakers to be careful when modifying the program to better address NBCR attacks: Simply expanding the program to require insurers to offer NBCR coverage may not achieve the desired outcomes. The authors identify program changes that will produce positive results for both NBCR and conventional attacks that are robust to key underlying uncertainties.
Formato:
Recursos electrónicos
Relevancia:
574.6224
por
Clark, Jean S.
Signatura topográfica preferida
610.285 23
Fecha de publicación
2010
Formato:
Recursos electrónicos
Relevancia:
1.3237
por
Reeves, Douglas B., 1953-
Signatura topográfica preferida
371.200973 22
Fecha de publicación
2009
Resumen
Guide for becoming a leader in making changes in the educational field.
Formato:
Recursos electrónicos
Relevancia:
1.2951
por
Wizemann, Theresa M.
Signatura topográfica preferida
362.18 23
Fecha de publicación
2011
Resumen
Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description.
Formato:
Recursos electrónicos
Relevancia:
0.9047
Limitar resultados de búsqueda
Limitado por: